These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16567878)

  • 1. Tuberculosis outcome monitoring--is it time to update European recommendations?
    Falzon D; Scholten J; Infuso A
    Euro Surveill; 2006; 11(3):20-5. PubMed ID: 16567878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tuberculosis annual report 2008--series 10. Treatment outcome and TB deaths].
    Research Institute of Tuberculosis, JATA
    Kekkaku; 2010 Aug; 85(8):683-6. PubMed ID: 20845689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the determinants of treatment success for tuberculosis cases in Europe.
    Falzon D; Le Strat Y; Belghiti F; Infuso A;
    Int J Tuberc Lung Dis; 2005 Nov; 9(11):1224-9. PubMed ID: 16333929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of tuberculosis treatment outcomes in the European Union and European Economic Area: efforts needed towards optimal case management and control.
    Manissero D; Hollo V; Huitric E; Kodmon C; Amato-Gauci A
    Euro Surveill; 2010 Mar; 15(11):. PubMed ID: 20338143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance of tuberculosis in Europe.
    Schwoebel V; Antoine D; Veen J
    Med Arh; 1999; 53(3 Suppl 1):9-10. PubMed ID: 10546459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculosis in European cities: establishment of a patient monitoring system over 10 years in Paris, France.
    Farge D; Porcher R; Antoun F; Fain O; Keshtmand H; Rocher G; Mallet HP; Rambeloarisoa J; Gerber F; De Castro N; Che D; Coulombier D; Zaleskis R; Herrmann JL; Dye C;
    Int J Tuberc Lung Dis; 2007 Sep; 11(9):992-8. PubMed ID: 17705977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of extensively drug-resistant tuberculosis in Europe, 2003-2007.
    Devaux I; Manissero D; Fernandez de la Hoz K; Kremer K; van Soolingen D;
    Euro Surveill; 2010 Mar; 15(11):. PubMed ID: 20338144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress in global tuberculosis control 1995-1996, with emphasis on 22 high-incidence countries. Global Monitoring and Surveillance Project.
    Netto EM; Dye C; Raviglione MC
    Int J Tuberc Lung Dis; 1999 Apr; 3(4):310-20. PubMed ID: 10206501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [European surveillance of tuberculosis: description of the network and recent results].
    Infuso A; Falzon D
    Med Mal Infect; 2005 May; 35(5):264-8. PubMed ID: 15885956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with poor tuberculosis treatment outcome in the Southern Region of Ethiopia.
    Muñoz-Sellart M; Cuevas LE; Tumato M; Merid Y; Yassin MA
    Int J Tuberc Lung Dis; 2010 Aug; 14(8):973-9. PubMed ID: 20626941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DOTS in Cambodia. Directly observed treatment with short-course chemotherapy.
    Norval PY; San KK; Bakhim T; Rith DN; Ahn DI; Blanc L
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):44-51. PubMed ID: 9562110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors determining the outcome of treatment of adult smear-positive tuberculosis cases in The Gambia.
    Lienhardt C; Manneh K; Bouchier V; Lahai G; Milligan PJ; McAdam KP
    Int J Tuberc Lung Dis; 1998 Sep; 2(9):712-8. PubMed ID: 9755924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reporting on multidrug-resistant tuberculosis: a proposed definition for the treatment outcome 'failed'.
    Chiang CY; Caminero JA; Enarson DA
    Int J Tuberc Lung Dis; 2009 May; 13(5):548-50. PubMed ID: 19383184
    [No Abstract]   [Full Text] [Related]  

  • 14. Tuberculosis trends in eastern Europe and the former USSR.
    Raviglione MC; Rieder HL; Styblo K; Khomenko AG; Esteves K; Kochi A
    Tuber Lung Dis; 1994 Dec; 75(6):400-16. PubMed ID: 7718828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is tuberculosis surveillance in the European Union telling us?
    Falzon D; Aït-Belghiti F
    Clin Infect Dis; 2007 May; 44(10):1261-7. PubMed ID: 17443460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis treatment outcome monitoring: Blackburn 1988-2000.
    Ormerod LP; Horsfield N; Green RM
    Int J Tuberc Lung Dis; 2002 Aug; 6(8):662-5. PubMed ID: 12150476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis in Europe: a problem of drug resistance or much more?
    Carvalho AC; Migliori GB; Cirillo DM
    Expert Rev Respir Med; 2010 Apr; 4(2):189-200. PubMed ID: 20406085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of patients treated for tuberculosis in Vaud County, Switzerland.
    Zellweger JP; Coulon P
    Int J Tuberc Lung Dis; 1998 May; 2(5):372-7. PubMed ID: 9613632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five year review of treatment outcome of directly observed therapy (DOT) for re-treatment pulmonary tuberculosis patients in UCH, Ibadan, Nigeria.
    Ige OM; Akindele MO
    Afr J Med Med Sci; 2011 Mar; 40(1):15-21. PubMed ID: 21834257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
    Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
    Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.